Contrasting ADMA Biologics (NASDAQ:ADMA) and Cardiac Biotech Solutions (OTCMKTS:CBSC)

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.

CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor

CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer

CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market

CB Scientific, Inc. Concludes its Annual Meeting of Stockholders

CB Scientific, Inc. 2023 Year in Review

CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP

CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand

CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC

CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand

CB Scientific, Inc. Announces Appointment of New Director for Asia Pacific